An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT07298239 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences